Chemed Corporation (CHE) Q3 2024 Earnings Call Transcript

Chemed Corporation (NYSE:CHE) Q3 2024 Earnings Conference Call October 30, 2024 10:00 AM ET

Company Participants

Holley Schmidt – Assistant Controller
Kevin McNamara – President and Chief Executive Officer
Mike Witzeman – Chief Financial Officer
Nick Westfall – Chairman and Chief Executive Officer, VITAS Healthcare Corporation

Conference Call Participants

Ben Hendrix – RBC Capital Markets
Joanna Gajuk – Bank of America

Operator

Good day and thank you for standing by. Welcome to the Chemed Corporation Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker’s presentation, there will be a question-and-answer session. [Operator Instructions]. Please be advised that today’s conference is being recorded.

I would now like to hand the conference over to your first speaker today, Holly Schmidt, Chemed, Assistant Controller. Please go ahead.

Holley Schmidt

Good morning. Our conference call this morning will review the financial results for the third quarter of 2024 ended September 30, 2020.

Before we begin, let me remind you that the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995 apply to this conference call. During the course of this call, the company will make various remarks concerning management’s expectations, predictions, plans and prospects that constitute forward-looking statements.

Actual results may differ materially from those projected by these forward-looking statements as a result of a variety of factors, including those identified in the company’s news release of October 25 and in various other filings with the SEC. You are cautioned that any forward-looking statements reflect management’s current view only and that the company undertakes no obligation to revise or update such statements in the future.

In addition, management may also discuss non-GAAP operating performance results during today’s call, including earnings before interest, taxes, depreciation and amortization, or EBITDA, and adjusted EBITDA. A reconciliation of these non-GAAP results is